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ABSTRACT 
Objective: This study investigated the association between electronic cigarette, or e-
cigarette, use after cessation treatment and tobacco abstinence at 12 months. It also 
examined characteristics of e-cigarette users and reasons for use.  
Methods: A longitudinal observational secondary analysis of self-reported e-cigarette 
use among adult Appalachian smokers enrolled in a tobacco dependence treatment trial 
(n=217) was conducted. Data were collected at baseline, 3, 6, and 12 months following 
treatment. 
Results: One in five participants reported using e-cigarettes post-treatment. Baseline 
sociodemographic and tobacco-related characteristics did not differ by e-cigarette use. 
Reasons participants cited for e-cigarette use included help in quitting, help in cutting 
down on cigarettes, and not as bad for health. Significantly fewer e-cigarette users than 
non-users were tobacco abstinent at the 12-month follow-up (4.7% vs. 19.0%, p=0.021). 
Conclusions: Among adult Appalachian smokers enrolled in tobacco cessation treatment, 
those that used e-cigarettes post-treatment were less likely to be tobacco abstinent after 
12 months. Additional high quality studies are needed to determine the effects of 
electronic cigarette use on long-term abstinence. 
Key Words: Electronic Cigarettes, E-Cigarettes, Cessation, Appalachia 
.   
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INTRODUCTION 
Tobacco use is the most preventable cause of disease and death in the United States1, 
yet in 2014, an estimated 16.8% of U.S. adults (18+) smoked cigarettes2. The majority of 
U.S. adult smokers want to quit3 and many are turning to electronic cigarettes, also 
known as e-cigarettes and e-cigs, as an alternative to smoking. E-cigarettes are battery-
operated devices that deliver nicotine, flavor, and other chemicals through an aerosol that 
is inhaled4. 
E-cigarettes have rapidly increased in popularity since their introduction to the United 
States market in 20075. The Food and Drug Administration (FDA) does not currently 
regulate e-cigarettes or endorse them as a strategy for quitting4, yet e-cigarettes have been 
marketed as cessation aids that are less harmful than traditional cigarettes6. Reported 
reasons for e-cigarette use among smokers include assistance to help quit or reduce 
smoking, reduced health risks, and maintenance of smoking in places where cigarettes are 
restricted7-10.  
About one in five current cigarette smokers report e-cigarette use some days and 
3.7% report daily use7. Among smokers, those who ever used e-cigarettes are more likely 
to be white8,11 and young adults9,11. In terms of tobacco-related characteristics, e-cigarette 
users have been found to have a higher motivation to quit and a higher quitting self-
efficacy12, use more quit methods (i.e. NRT), and are more nicotine dependent13, more 
likely to have made a quit attempt in the past year and more likely to live and/or work 
with other tobacco users than non e-cigarette users8.  
Two clinical trials have examined the efficacy of e-cigarettes as a cessation aid. The 
first, a randomized controlled trial conducted in New Zealand found that e-cigarettes are 
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modestly effective at helping current smokers quit, but superiority of e-cigarettes over the 
nicotine patch was not found14. The second trial was conducted in Italy and demonstrated 
that among smokers not intending to quit, e-cigarette use decreased cigarette 
consumption15.  
A few observational studies have likewise found that e-cigarette use helps smokers 
quit or reduces cigarette consumption. A cross-sectional study in the UK found that 
among adults smokers who had made a previous quit attempt in the past year, e-cigarette 
users were more likely to report abstinence than those who used NRT bought over-the-
counter (OR, 2.23; 95% CI 1.70-2.93) or no aid (OR, 1.38; 95% CI, 1.08-1.76)16. Other 
studies have noted that e-cigarettes reduced the urge to smoke14, 17-19 and aided in 
reducing cigarette consumption 20-21.   
In contrast, a meta-analysis of five population-based studies noted that e-cigarette use 
was associated with significantly lower odds of smoking cessation (OR, 0.61; 95% CI, 
0.50-0.75). Three of the studies in this meta-analysis did not control for nicotine 
dependence and the authors proposed that possibly those who use e-cigarettes are more 
nicotine dependent and experience greater difficulty quitting in general22. A recent 
random effects meta-analysis of twenty studies likewise found that the odds of quitting 
cigarettes were 28% lower in those who used e-cigarettes compared with those who did 
not use e-cigarettes (OR, 0.72; 95% CI 0·57-0·91) 23. This meta-analysis included studies 
of all smokers using e-cigarettes and studies of only smokers interested in quitting. The 
association between e-cigarette use and cessation did not differ between study 
characteristics. Importantly, this study concludes that e-cigarette use is associated with 
less quitting.  
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Only a few studies have investigated e-cigarette use among smokers who are trying to 
quit. Vickerman et al. reported that among state tobacco quit-line callers, e-cigarette users 
had a significantly lower 30-day point prevalence abstinence rate at the 7-month follow-
up compared with never users8. Similarly, among patients with cancer who were enrolled 
in a tobacco cessation study, e-cigarette users were twice as likely to be smoking at the 
time of follow-up as nonusers24. In a study among participants enrolled in a web-based 
smoking cessation trial, e-cigarette use was negatively associated with 3-month 
abstinence, but became insignificant when adjusted for use of other cessation aids13.  
There is a lack of scientific consensus on the impact of electronic cigarette use on 
tobacco cessation. While randomized controlled trials have found that e-cigarettes help 
smokers quit, observational studies and meta-analyses have found the opposite. 
Moreover, observational studies in the UK have found that e-cigarette users are more 
likely to quit, while in the United States e-cigarettes are associated with less quitting. 
More research is clearly needed.  
However, regulatory restrictions in the United States make it difficult to conduct 
randomized controlled trials to determine the efficacy of e-cigarette devices. At present, 
there is no publically available data for e-cigarette manufacturing, design or preclinical 
studies that are suitable for meeting the requirements of an Investigational New Drug 
application25. As such, testing the efficacy of e-cigarettes through randomized controlled 
trials cannot occur. Thus, public health experts and clinicians increasingly rely on 
findings from observational studies when making recommendations to current smokers 
about the effectiveness of e-cigarettes in promoting cessation.  
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In this paper, we describe e-cigarette use among Ohio Appalachian adults who want 
to quit smoking and are enrolled in a tobacco cessation treatment trial. The purposes of 
this secondary analysis were to 1) examine sociodemographic and tobacco-related 
characteristics associated with e-cigarette use post-treatment, 2) describe reasons for e-
cigarette use at 3, 6, and 12 months, and 3) determine the association between e-cigarette 
use post-treatment and biochemically confirmed 7-day point prevalence tobacco 
abstinence at 12 months. 
METHODS 
Study Overview 
A secondary analysis was conducted using data obtained during a tobacco cessation 
treatment trial that was implemented in 12 federally designated Ohio Appalachian 
counties31. Six counties each were randomly assigned to one of two study conditions. 
Both conditions included standardized cognitive-behavioral counseling and free nicotine 
replacement therapy (NRT) in the form of a daily 21 mg patch for 8 weeks, as 
recommended by the US Public Health Service Treating Tobacco Use and Dependence 
guideline26. Smokers in one condition received face-to-face counseling from trained 
community health workers while participants in the other condition were referred to the 
Ohio Tobacco QUIT LINE. Data were collected at baseline and 3, 6, and 12 months 
following treatment and all participants were given an incentive in appreciation of their 
participation in the study. The study, approved by the university’s Institutional Review 
Board, was conducted in three waves (2010-2014), with one-third of the face-to-face and 
one-third of the quit-line counties included in each wave.  
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Procedure 
Recruitment occurred at a variety of community sites within each county that were 
geographically and socioeconomically distributed. Eligibility criteria included: 1) age 18 
years and older; 2) current self-reported use of a combustible tobacco product on a daily 
basis; 3) resident of one of the 12 participating counties; 4) absence of clinical condition 
that contraindicated use of over-the-counter NRT; 5) if female, non-pregnant, as 
confirmed by urine human chorionic gonadotropin test; 6) willing to participate in study 
protocol; and, 7) able to provide written informed consent. A trained county interviewer 
contacted potential participants who were eligible and administered a face-to-face 
questionnaire.  
Sample 
Participants from the face-to-face and quit-line conditions were combined for this 
secondary analysis. Initial data collection started in November 2010; however, items to 
assess e-cigarette use were added to the existing surveys in April 2012 due to the 
increasing widespread marketing of e-cigarette products. This paper reports on the subset 
of the sample that completed baseline surveys from April 2012 to October 2013 and is 
restricted to only those participants who provided complete answers to use of other 
tobacco products, including e-cigarettes, at baseline, 3, 6, and 12 months (n=217). 
Measures 
Sociodemographic and tobacco-related characteristics were collected in the baseline 
survey questionnaire. Sociodemographic characteristics were comprised of age, gender, 
race, education, poverty level, self-rated health and health insurance status. Smoking 
variables included years smoked, age started smoking, number of cigarettes smoked per 
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day, and Fagerström Test for Nicotine Dependence (FTND)27. Quitting variables assessed 
number of previous quit attempts, use of quitting resources in the past, the Decisional 
Balance Scale for Smoking28, confidence to quit, and Quitting Self-Efficacy Score29. 
Smoking policies included indoor home smoking rules (i.e. allowed anywhere inside the 
home, allowed in some places or at sometimes, not allowed anywhere inside the home) 
and whether a worksite smoking policy existed.  
Those who reported e-cigarette use were asked about their reasons for use at every 
time point. Six categories of reasons were given: 1) they may not be as bad for your 
health; 2) they taste better; 3) they make it easier for you to cut down on the number of 
cigarettes you smoke; 4) so you can smoke in places where smoking regular cigarettes is 
banned; 5) they may help you quit; and, 6) they are cheaper. Participants were instructed 
to indicate all reasons that applied.  
The main exposure variable of interest was e-cigarette use post-treatment. At 3, 6 and 
12 month follow-ups, participants were asked if they used any kind of tobacco other than 
cigarettes in the past 7 days. If they answered yes, they were asked if they currently use 
e-cigarettes every day, some days, or not at all. The variable, “e-cigarette use post-
treatment” was defined as self-reported past 7-day e-cigarette use (every day or some 
days) at 3, 6, and/or 12 months.  
The primary outcome measure was 7-day point prevalence abstinence from tobacco 
(not including e-cigarettes) at 12 months post-treatment. Abstinence was defined as self-
report of no tobacco use in the past 7 days as confirmed by a saliva cotinine concentration 
of <15 ng/mL, or by expired air carbon monoxide level of < 8 parts per million if 
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participant was using NRT or e-cigarettes30. Seven-day point prevalence tobacco 
abstinence was also determined at 3 and 6 months.  
In addition to baseline characteristics, other potential confounders included total 
number of in-person counseling visits and number of patches used (face-to-face 
condition) and number of calls to the quit-line and number of weeks of patches received 
(quit-line condition).  
Statistical Analysis 
The data were analyzed in STATA. Sociodemographic and tobacco-related 
characteristics were compared between those who used e-cigarettes post-treatment and 
those who never used e-cigarettes post-treatment. Means and t-tests were used for 
continuous variables and percentages, chi-square tests and Fisher’s exact tests were used 
for categorical variables. No correction was made for multiple comparisons, but the p-
values are provided for descriptive purposes.  
For the primary analysis, a Fisher’s exact test assessed the association between use of 
e-cigarettes post-treatment and 12-month point prevalence tobacco abstinence. A mixed 
effects logistic regression analysis evaluated the impact of potential confounders and the 
impact of within county correlation. These models indicated that the within county 
correlation on the outcome was zero, so the presented analyses utilize methods for 
independent data. 
RESULTS 
Among the 217 participants who provided complete data, approximately one in five 
(19.8%) reported e-cigarette use post-treatment. The percentage of e-cigarette users 
generally increased over time: 7.8% at 3 and 6 months and 12.0% at 12 months. 
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Characteristics of E-cigarette Users 
Baseline sociodemographic characteristics were not generally different between e-
cigarette users and non-users post-treatment (Table 1). The majority of e-cigarette users 
were 25-54 years old (53.5%), female (76.7%), and white (97.6%). More than half of e-
cigarette users had more than a high school degree or General Educational Development 
(GED) (58.1%). Approximately 13% lived below the 100% federal poverty level and 
23% did not have health insurance. These characteristics were similar to the 
characteristics of non-users and the sample as a whole31. Some difference was found 
between e-cigarette users and non-users in self-rated health with 51% of e-cigarette users 
reporting fair or poor health, as compared to 30% among never users (p=0.020). 
 
Table 1. Sample baseline sociodemographic characteristics of smokers enrolled in a 
tobacco cessation treatment trial by use of e-cigarettes post-treatment (n=217). 
 
 
 
Ever use of e-cig post-
treatment (n=43) 
 
Never use e-cig post-
treatment (n=174) 
 
 
p value 
 
Age, % 
   18-24 
   25-54 
   ≥ 55 
 
2.3 
53.5 
44.2 
 
3.5 
61.5 
35.1 
 
0.59 
Gender, % 
   Female 
 
76.7 
 
68.4 
 
0.28 
Race, % 
   White 
   Other 
 
97.6 
2.4 
 
94.2 
5.8 
 
0.70 
Appalachian Status, % 
   Appalachian 
   Not Appalachian 
   Don’t Know 
 
32.6 
8.1 
9.3 
 
43.1 
50.6 
6.3 
 
0.39 
Education, % 
   Less than High School (HS) 
   HS/GED 
   More than HS/GED 
 
16.3 
25.6 
58.1 
 
8.7 
37.0 
54.3 
 
0.19 
Poverty level, % 
   Below 100% poverty 
 
16.7 
 
15.0 
 
0.79 
Self-rated health, % 
   Excellent, very good 
   Good 
   Fair, poor 
 
14.0 
34.9 
51.2 
 
29.9 
40.2 
29.9 
 
0.020 
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Smoking history variables did not differ significantly by e-cigarette use post-
treatment (Table 2). On average, e-cigarette users smoked cigarettes for 31 years and 
started smoking around age 17. They smoked approximately 20 cigarettes/day. E-
cigarette users on average showed moderate nicotine dependence, based on FTND scores. 
E-cigarette users did not differ from non-users in their nicotine dependence. 
There were likewise no associations between baseline quitting history variables and 
e-cigarette use (Table 2). In the past 12 months, on average, e-cigarette users attempted to 
quit one time for at least 24 hours. Approximately three-quarters of e-cigarette users had 
used resources in the past to aid in quitting (i.e. NRT, other medication, quit-lines, 
community or internet programs, self-help materials, and healthcare providers). On a 
scale from 1 to 10 (1 = not at all confident and 10 = extremely confident) e-cigarette 
users on average scored 7 in their confidence to quit smoking.  
Possible differences were found regarding smoking policies (Table 2). While 56% 
of e-cigarette users were allowed to smoke anywhere inside the home, only 39% of non-
users had this same rule (p=0.068). Fewer e-cigarette users had a smoking policy at work 
(67% vs. 85%, p=0.10). However, these differences were not statistically significant. 
 
Table 2. Sample baseline tobacco-related characteristics of smokers enrolled in a tobacco 
cessation treatment trial by use of e-cigarettes post-treatment (n=217). 
 
 
 
Ever use of e-cig post- 
treatment (n=43) 
 
Never use e-cig post- 
treatment (n=174) 
 
 
p value 
 
Years Smoked, Mean ± SD 31.2  ± 14.9 30.8  ± 14.1 0.87 
Age Started smoking, Mean ± SD 16.9  ± 6.5 17.9  ± 6.6 0.38 
Cigarettes per day, Mean ± SD 22.0  ± 14.2 21.2  ± 9.7 0.67 
Fagerström score, Mean ± SD 5.7  ± 1.9 5.1  ± 2.3 0.18 
Quit attempts, past 12 mo, Mean ± SD 1.1 ± 1.4 1.6 ± 3.6 0.39 
Used resources in past, % 
   Yes 
 
76.9 
 
77.2 
 
0.97 
Used NRT in past, % 
   Yes 
 
58.1 
 
50.6 
 
0.37 
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Decisional Balance Scale for Smoking 
(pros-cons), Mean ± SD 
 
-0.37  ± 3.2 
 
-0.32  ± 2.9 
 
0.92 
Confidence can quit, Mean ± SD 7.3  ± 1.8 7.1  ± 2.0 0.53 
Quitting self-efficacy: positive/social, 
   Mean ± SD 
 
10.5  ± 3.1 
 
10.5  ± 2.7 
 
0.97 
Quitting self-efficacy: negative/ 
affective, Mean ± SD 
 
12.2 ± 3.0 
 
12.7 ± 2.2 
 
0.19 
Quitting self-efficacy: habit/addictive,  
   Mean ± SD 
 
9.8 ± 2.3 
 
10.1 ± 2.3 
 
0.46 
Indoor home smoking rule, % 
Allowed anywhere inside the home 
Allowed in some places or at 
sometimes 
Not allowed anywhere inside the 
home 
 
55.8 
 
18.6 
 
25.6 
 
39.1 
 
35.6 
 
25.3 
 
0.07 
Smoking policy at work, n=100, % 
   Yes 
(n=16) 
66.7 
(n=84) 
84.5 
 
0.10 
 
Reasons for E-cigarette Use 
At every follow-up, the top three reasons for e-cigarette use were: 1) help in quitting; 
2) help in cutting down on cigarettes; and, 3) not as bad for health (Figure 1). 
Interestingly, the reported reasons for use diminished over time. For example, while 53% 
of e-cigarette users reported that “they make it easier for you to cut down on the number 
of cigarettes you smoke” at 3 months, only 18% and 15% reported this reason at 6 and 12 
months, respectively.  
Figure 1. Percent of reported reasons for e-cigarette use at 3, 6, and 12 months.  
 
0 
10 
20 
30 
40 
50 
60 
70 
Not as bad 
for health 
Taste better Cut down on 
cigarettes 
Can smoke in 
places where 
cigarettes are 
banned 
Might help 
you quit 
Cheaper 
Pe
rc
en
t 
3-month (n=17) 6-month (n=17) 12-month (n=26) 
 13  
 
E-cigarette Use and Tobacco Cessation 
The association between e-cigarette use post-treatment and biochemically-confirmed 
tobacco abstinence at 3, 6, and 12 months is presented in Figure 2. At every follow-up, 
more participants who never used e-cigarettes post-treatment were tobacco abstinent 
compared to participants who used e-cigarettes post-treatment. This trend was not 
significant at 3 months (p=0.46) and 6 months (p=0.25), but was significant at 12 months 
(p=0.021). Specifically, four times as many never e-cigarette users were tobacco 
abstinent at 12-months, as compared to those who used e-cigarettes post-treatment 
(19.0% vs. 4.7%).   
 
Figure 2. Percent abstinent (SEM) at 3, 6, and 12 months according to e-cigarette use 
post-treatment (n=217).  
 
 
Adherence to the treatment protocol was not found to confound the association (Table 
3). Use of e-cigarettes did not differ between the two conditions, face-to-face versus quit-
line (p=0.49). In the face-to-face condition, there were no statistically significant 
differences between e-cigarette users and non-users in total number of in-person 
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counseling visits (p=0.66). While never users were more adherent to using nicotine 
patches, this difference was not significant at the 0.05 level (p=0.10). In the quit-line 
condition, there were no statistically significant differences between e-cigarette users and 
non-users in number of calls to the quit-line (p=0.53) and number of weeks of patches 
received (p=0.76).  
 
Table 3. Adherence to counseling and medication by e-cigarette use post-treatment 
(n=217). 
 
 
 
 Ever use of e-cig 
post- treatment  
 
Never use e-cig 
post- treatment  
 
 
p value 
 
Condition (%) (n=217) 
Face-to-Face 
Quit-line 
(n=43) 
60.5 
39.5 
(n=174) 
54.6 
45.4 
 
0.49 
 
Face-to-Face (n=121) 
 
(n=26) 
 
(n=95) 
 
Number of in-person counseling 
visits (Range 0-7) 
   Mean ± SD 
 
 
6.5 ± 0.91 
 
 
6.4 ± 1.4 
 
 
0.66 
Number of patches used 
   0-27 
   28-55 
   56 or more 
 
26.9 
57.7 
15.4 
 
16.8 
46.3 
36.8 
 
0.10 
Quit-line (n=96) (n=17) (n=79)  
Number of quit-line counseling calls, 
   Mean ± SD 
 
3.6 ± 2.7 
 
3.2 ± 1.9 
 
0.76 
Number of weeks of patches 
received  
   No weeks 
   2-4 weeks 
   More than 4 weeks 
 
 
11.8 
35.3 
52.9 
 
 
16.5 
34.2 
49.4 
 
 
0.99 
 
DISCUSSION 
Among adult Appalachian smokers who were enrolled in a tobacco cessation trial, 
post-treatment e-cigarette users were less likely to achieve biochemically-validated 
abstinence at 12 months follow-up, as compared to non-users. This finding adds to the 
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growing number of observational studies8,13,22-24 that have found that e-cigarette use 
decreases the likelihood that a smoker will successfully quit.  
Past studies, including a recent meta-analysis published in the Lancet23, have been 
criticized32 for containing studies that assessed past e-cigarette use among current 
smokers and thus excluding people who used e-cigarettes and successfully stopped 
smoking. The strength of this study is that we examined e-cigarette use and abstinence 
among participants who intended to quit upon enrollment. This design therefore 
accounted for those who used e-cigarettes and then quit. Our results support past findings 
that e-cigarette use is associated with less success in quitting.  
E-cigarette users did not differ from never users in their baseline smoking history, 
including nicotine dependence, quit attempts in the past year, and use of cessation aids in 
the past. Moreover, e-cigarette users did not appear to differentially engage in the tobacco 
cessation intervention. These findings contradict previous observational studies reporting 
that e-cigarette use is associated with greater nicotine dependence13, higher number of 
past-year quit attempts8, and use of more quit methods8,13. The reasons for these 
differences are not readily apparent but may be partially explained by lack of preventive 
services and cessation resources in this medically underserved area of the state33,34. While 
past studies have identified nicotine dependence and past NRT use as potential 
confounders in the association between e-cigarette use and tobacco cessation, our study 
does not support this idea.  
The primary reasons cited for e-cigarette use included help in quitting and cutting 
down on cigarettes, and they are not as bad for health, all of which agree with previous 
findings7-10. These reasons resonate with marketing messages that e-cigarettes are less 
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harmful than traditional cigarettes and can help smokers to quit. Consumers have 
responded to these perceptions regardless of evidence. Additionally, an interesting result 
was that e-cigarette users at 3 months (end of treatment) reported many reasons for use, 
but at 6 and 12 months fewer participants reported each reason. Potentially, over time a 
regular pattern of e-cigarette behavior takes over, and the intent of quitting is replaced 
with the routine use of an additional product. 
This study had several limitations. First, this study had a small sample size, as e-
cigarette use questions were added to the baseline survey after the majority of 
participants had been enrolled. This late addition was prompted by the widespread 
marketing of e-cigarette products that was initiated after our study started.  
Second, the follow-up question used to identify e-cigarette users at 3, 6, and 12 
months post-treatment only screened for e-cigarette use in the past 7 days and thus 
potential e-cigarette users were likely missed. This may explain some of the lack of 
difference between groups, but suggests that perhaps the association between e-cigarette 
use and 12 month abstinence is underestimated.  
Third, this study does not differentiate between type of e-cigarette device or the 
amount of nicotine in the device. Another limitation is the homogenous study population 
representing those trying to quit and living in Appalachian Ohio. On the other hand, this 
population is representative of those residing in a region characterized by a high 
prevalence of smoking32. Finally, the design was observational, which limits any causal 
inferences about e-cigarette use post-treatment for tobacco cessation. 
Despite these limitations, this study adds to our limited understanding of e-cigarette 
use among a population that is seriously trying to quit smoking. It supports the growing 
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findings that e-cigarette users are less likely to successfully quit smoking. However, the 
effect of electronic cigarette use on smoking cessation remains controversial and lacks 
consensus. For example, policy experts in England are taking a harm-reduction approach 
and encouraging smokers to try vaping as their interpretation of findings suggests that 
smokers who use e-cigarettes are more likely to quit smoking 16,32,35.  
Further high quality research studies are critically needed to determine the effect of e-
cigarette use on smoking cessation. Given that e-cigarettes are not regulated or approved 
by the FDA, they cannot be tested via randomized controlled trials. Therefore, in the 
U.S., large, prospective cohort studies are needed. This evidence is essential for smokers 
to make informed decisions on whether to use e-cigarettes while trying to quit and to 
assist clinicians to effectively advise their patients about these products. Notably, the 
results will provide the FDA with evidence to assist in the development of appropriate 
regulatory actions, especially with regard to cessation claims surrounding e-cigarettes. 
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